New Study Suggests At-Home Fingerprick Test Could Identify Alzheimer's Risk
A recent study published in Nature Communications reveals that a simple at-home fingerprick test, combined with online cognitive assessments, could effectively identify individuals at risk of Alzheimer's disease. The research demonstrates that self-collected capillary blood samples, when analyzed for plasma phosphorylated tau at amino acid 217 (p-tau217) and glial fibrillary acidic protein (GFAP), align closely with traditional venous blood biomarkers. This method, which allows for remote and accessible dementia risk screening, could significantly enhance early detection efforts. The study involved 174 participants, including those with mild cognitive impairment and Alzheimer's dementia, and found that elevated levels of these biomarkers were associated with cognitive decline. The approach is intended for risk stratification rather than diagnosis, aiming to extend risk assessment beyond specialist settings. 
